Guizhou Xinbang Pharmaceutical Co., Ltd.

¥3.05As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002390Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (10.64%)
Div yield 2.95%
ROE 3.35%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.06
PE TTM 41.80
TSR TTM (17.77%)
Mkt cap ¥5.784B
ROIC 4.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.39
11.21%
(83.25%)
Hold 10|0|12|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.04
24.43%
21.08%
15.07%
18.01%
Revenue¥M
249.8
262.9
267.5
269.4
(1.49%)
3.52%
5.27%
7.33%
Peers (US$867.0M)
Cap (US$)
PE
866.6M
46.93x
864.4M
29.67x
872.1M
978.4x
Capital
TTM
5Y
10Y
Leveragex
1.399
(0.824)
(0.608)
EBIT/Intx
0.977
1.022
0.780
Own earn%
62.30
(127.43)
(98.56)
Sh yield%
30.69
25.12
27.85
Owners
Insiders/Inst%
4.04
62.19
Short interest%
5.40
SBC / revenue%
2.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
7–15
$1 testx
—
Incr. ROIC%
3